Katharine Gammon is an award-winning independent science journalist based in Santa Monica, California. Her work has appeared in The New York Times, The Atlantic, WIRED, The Guardian, Undark, Popular Science, MIT Technology Review, Nature, Hakai and beyond.
Katharine Gammon
From this contributor
Spotted around the web: Mapping histones; COVID-19 births; acetaminophen lawsuits
Here is a roundup of news and research for the week of 31 October.
Spotted around the web: Mapping histones; COVID-19 births; acetaminophen lawsuits
By
Jill Adams, Katharine Gammon, Peter Hess, Nicholette Zeliadt
4 November 2022 | 3 min read
A mix of common and rare variants shapes autism inheritance patterns
The study also reveals a link between language development and common variants.
A mix of common and rare variants shapes autism inheritance patterns
By
Katharine Gammon
4 November 2022 | 3 min read
Zebrafish point to new gene involved in brain overgrowth, autism
The gene, YTHDF2, has not previously been linked to autism.
Zebrafish point to new gene involved in brain overgrowth, autism
By
Katharine Gammon
1 November 2022 | 3 min read
Lags in genetic testing, variant reporting hinder autism research
Few autistic people undergo the recommended genetic testing for their condition, and test results often do not make their way into public databases, where researchers and clinicians can learn from them.
Lags in genetic testing, variant reporting hinder autism research
By
Katharine Gammon
28 October 2022 | 4 min read
Explore more from The Transmitter
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
By
Claudia López Lloreda
3 February 2026 | 4 min read
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
By
Calli McMurray
3 February 2026 | 5 min read
Cell atlas cracks open ‘black box’ of mammalian spinal cord development
The atlas details the genetics, birth dates and gene-expression signatures of roughly 150 neuron subtypes in the dorsal horn of the mouse spinal cord.
Cell atlas cracks open ‘black box’ of mammalian spinal cord development
The atlas details the genetics, birth dates and gene-expression signatures of roughly 150 neuron subtypes in the dorsal horn of the mouse spinal cord.
By
Natalia Mesa
3 February 2026 | 5 min read